Canada High Court delivers good news to patent owners
10 November 2008
Eileen McDermott, New York
The Supreme Court has clarified the tests for anticipation and obviousness and reaffirmed the patentability of selection patents in a ruling that could be a boon for Canadian pharmaceutical companies, as well as patentees in general
The judgment, authored by Justice Marshall Rothstein, upheld Canadian pharmaceutical company Sanofi-Aventis's patent for Plavix (clopidogrel bisulfate), a popular blood clot inhibitor, rejecting generic drug company Apotex's claims that the patent...
Only subscribers have complete access to Managing IP Magazine,
log in or
subscribe now.
Alternatively take a
free trial, giving you 48-hour access to Managing IP Magazine (some articles and surveys may be excluded).
Subscribe Now
This article is available to subscribers. Please click subscribe to read the rest of the article.
Subscribe
Take a free trial
Please take a free 48-hour trial to gain limited access. Some articles and surveys may be excluded.
Take a free trial